ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert B. Mammana
Sidney Levitsky
Charles B. Beckman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mammana, R. B.
Right arrow Articles by Sernaque, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mammana, R. B.
Right arrow Articles by Sernaque, D.

Ann Thorac Surg 1981;31:347-349
© 1981 The Society of Thoracic Surgeons


Articles

Systemic Effects of Multidose Hypothermic Potassium Cardioplegia

Robert B. Mammana, M.D.*, Sidney Levitsky, M.D., Charles B. Beckman, M.D., Andre Vasu, M.D., David Sernaque, M.D.

Department of Surgery, the Abraham Lincoln School of Medicine of the University of Illinois College of Medicine and the West Side Veterans Administration Medical Center, Chicago, IL

Accepted for publication August 18, 1980.

* Address reprint requests to Dr. Mammana, Division of Cardiothoracic Surgery, University of Arizona Health Science Center, Tucson, AZ 85724

The purpose of this study was to investigate the changes in serum and urine potassium before, during, and after the administration of potassium cardioplegia using a solution containing 28 mEq/L of potassium chloride in 20 consecutive patients with acquired heart disease. The data obtained suggest that the concentration of potassium administered does not result in inordinately elevated serum potassium levels (peak, 4.6 ± 0.18 mEq/L at 2 hours of multidose hypothermic potassium cardioplegia) during or after infusion. Additionally, the urinary excretion of potassium increased during infusion and eventually exceeded the amount of potassium infused. While hypothermic potassium cardioplegia appears to be a safe and efficient method of myocardial protection, continued surveillance of postoperative potassium levels remains necessary to detect obligatory urinary potassium excretion following cardiopulmonary bypass and operation.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
D. O. Weber and M. D. Yarnoz
Hyperkalemia Complicating Cardiopulmonary Bypass: Analysis of Risk Factors
Ann. Thorac. Surg., October 1, 1982; 34(4): 439 - 445.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The Society of Thoracic Surgeons.